Proxibarbital
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 5-allyl-5-(2-hydroxypropyl)pyrimidine-2,4,6(1H,3H,5H)-trione | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 2537-29-3 |
| ATC code | N05CA22 |
| PubChem | CID 17336 |
| ChemSpider | 16406 |
| Synonyms | Proxibarbital, Centralgol, Ipronal, 5-Allyl-5-(β-hydroxypropyl)barbituric acid |
| Chemical data | |
| Formula | C10H14N2O4 |
| Mol. mass | 226.229 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Proxibarbital (Ipronal) is a barbiturate derivative synthesized in 1956. It has anti-anxiety properties and in contrast to most barbiturates almost without hypnotic action.[1]
It was also used in the treatment of migraine headaches in a similar manner to butalbital.[2]
[edit] References
- ^ Zajdel, P.; Kulig, K.; Zejc, A. (2008). Zejc, A.; Gorczyca, M.. eds (in polish). Chemia leków, podręcznik dla studentów farmacji i farmaceutów. Warszawa, Poland. ISBN 9788320036527.
- ^ Sulman, F. G.; Pfeifer, Y.; Tal, E. (1976). "Migraine therapy by enzyme induction with proxibarbital" (in german). Therapie der Gegenwart 115 (12): 2088–2103. PMID 14412.
|
|||||||||||||||||||||||||||||
| This sedative-related article is a stub. You can help Wikipedia by expanding it. |